The
proportion of approved chiral drugs and drug candidates
under
medical studies has surged dramatically over the past two decades.
As a consequence, the efficient synthesis of enantiopure pharmaceuticals
or their synthetic intermediates poses a profound challenge to medicinal
and process chemists. The significant advancement in asymmetric catalysis
has provided an effective and reliable solution to this challenge.
The successful application of transition metal catalysis, organocatalysis,
and biocatalysis to the medicinal and pharmaceutical industries has
promoted drug discovery by efficient and precise preparation of enantio-enriched
therapeutic agents, and facilitated the industrial production of active
pharmaceutical ingredient in an economic and environmentally friendly
fashion. The present review summarizes the most recent applications
(2008–2022) of asymmetric catalysis in the pharmaceutical industry
ranging from process scales to pilot and industrial levels. It also
showcases the latest achievements and trends in the asymmetric synthesis
of therapeutic agents with state of the art technologies of asymmetric
catalysis.